Doctors Ponder FDA Drug Controversy
15218
Startling testimony by an FDA drug safety reviewer about five popular medications has the medical world buzzing about how tightly the agency should be regulating new medications.
339490
CHICAGO A leading doctor says physicians and patients are obliged to keep a close watch on new prescription drugs for side effects.
174927
Pressure is building against the widely reported gifts and other potential conflicts between drug companies and doctors.
387871
Oct. 6, 2004 - Scientists in the United States and regulatory agencies in Europe on Wednesdsay questioned whether Celebrex and other pain relievers might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
63282
The potential heart risks of GlaxoSmithKline Plc's diabetes drug Avandia are still not clear, the head of the U.S. Food and Drug Administration told lawmakers who questioned the agency's oversight of the widely used pill on Wednesday.
217268
Federal regulators urged doctors Thursday to think twice before prescribing several popular but controversial painkillers for patients with histories of heart trouble.
3564
A day after troubling reports about the popular pain relief drug Celebrex, more questions are being asked about the approval process for such drugs.
602553
U.S. lawmakers criticized the Food  and Drug Administration's monitoring of the risks of a  Sanofi-Aventis antibiotic and some other prescription drugs on  Tuesday.
44020
Nearly 20 percent of U.S. Food and  Drug Administration scientists surveyed in late 2002 said they  were pressured to approve or recommend approval of a medicine  despite their reservations about the drug's risks or  effectiveness, according to documents made public on Thursday.
458929
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc and Schering-Plough's cholesterol medicine Vytorin  following the drug's failure to work better than a generic drug  in a study of plaque build-up in neck arteries.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
582657
New reports suggest another drug company moved too slowly to pull a dangerous medication from the market and question the Food and Drug Administration&#39;s ability to protect the public.
328328
An Oregon man stopped taking the painkiller Vioxx when it was pulled from the market, switching to Bextra. Then questions were raised about Bextra &#151; and four other drugs &#151; and he returned to his doctor with a new set of worries. Similar conversations are happening between doctors and patients all around the country.
719234
US Food and Drug Administration staff reviewers on Tuesday questioned clinical data for non-Hodgkin&#39;s lymphoma drug Marqibo, made by Inex Pharmaceuticals Corp.
95505
The recent Vioxx withdrawal and  testimony from an FDA insider accusing the agency of failing to  protect public health are fueling such heightened concern over  drug safety that valuable medicines could be kept from  patients, doctors said on Friday.
41829
The Food and Drug Administration of the US found itself in the midst of a rather unpleasant controversy. Recently the chief of Cleveland Clinic Foundationâs department of cardiovascular medicine blamed this
379737
Federal advisers who met last week to consider whether to restrict doses of popular antianemia drugs were themselves under scrutiny during the hearing. The Food and Drug Administration is considering a top-to-bottom reshaping of how it picks and uses the outside scientists who serve on the agency's advisory panels.